Home
/
Elevance Health, Inc.
/
Financials
/
Quarterly
Elevance Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Elevance Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$50.71B
Oct 21, 2025
Q2
2025
Jun 30, 2025
$49.78B
Jul 17, 2025
Q1
2025
Mar 31, 2025
$48.89B
Apr 22, 2025
Q3
2025
Sep 30, 2024
$45.11B
Oct 21, 2025
Q2
2025
Jun 30, 2024
$43.89B
Jul 17, 2025
Q1
2025
Mar 31, 2024
$42.58B
Apr 22, 2025
Q3
2024
Sep 30, 2023
$42.85B
Oct 17, 2024
Q2
2024
Jun 30, 2023
$43.67B
Jul 17, 2024
Q1
2024
Mar 31, 2023
$42.17B
Apr 18, 2024
Q3
2023
Dec 31, 2022
$156.60B
Oct 18, 2023
Q3
2023
Sep 30, 2022
$39.94B
Oct 18, 2023
Q2
2023
Jun 30, 2022
$38.63B
Sep 29, 2023
Q1
2023
Mar 31, 2022
$38.10B
Apr 19, 2023
Q3
2023
Dec 31, 2021
$138.64B
Oct 18, 2023
Q3
2022
Sep 30, 2021
$35.82B
Oct 19, 2022
Q2
2022
Jun 30, 2021
$33.85B
Jul 20, 2022
Q1
2022
Mar 31, 2021
$32.39B
Apr 20, 2022
Q3
2023
Dec 31, 2020
$121.87B
Oct 18, 2023
Q3
2021
Sep 30, 2020
$31.16B
Oct 20, 2021
Q2
2021
Jun 30, 2020
$29.26B
Jul 21, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.19B
Oct 21, 2025
Q2
2025
Jun 30, 2025
$1.74B
Jul 17, 2025
Q1
2025
Mar 31, 2025
$2.18B
Apr 22, 2025
Q3
2025
Sep 30, 2024
$1.02B
Oct 21, 2025
Q2
2025
Jun 30, 2024
$2.30B
Jul 17, 2025
Q1
2025
Mar 31, 2024
$2.25B
Apr 22, 2025
Q3
2024
Sep 30, 2023
$1.29B
Oct 17, 2024
Q2
2024
Jun 30, 2023
$1.85B
Jul 17, 2024
Q1
2024
Mar 31, 2023
$1.99B
Apr 18, 2024
Q3
2023
Dec 31, 2022
$5.89B
Oct 18, 2023
Q3
2023
Sep 30, 2022
$1.60B
Oct 18, 2023
Q2
2023
Jun 30, 2022
$1.64B
Sep 29, 2023
Q1
2023
Mar 31, 2022
$1.79B
Apr 19, 2023
Q3
2023
Dec 31, 2021
$6.16B
Oct 18, 2023
Q3
2022
Sep 30, 2021
$1.51B
Oct 19, 2022
Q2
2022
Jun 30, 2021
$1.79B
Jul 20, 2022
Q1
2022
Mar 31, 2021
$1.67B
Apr 20, 2022
Q3
2023
Dec 31, 2020
$4.57B
Oct 18, 2023
Q3
2021
Sep 30, 2020
$222.00M
Oct 20, 2021
Q2
2021
Jun 30, 2020
$2.28B
Jul 21, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.30B
Oct 21, 2025
Q2
2025
Jun 30, 2025
$2.43B
Jul 17, 2025
Q1
2025
Mar 31, 2025
$3.17B
Apr 22, 2025
Q3
2025
Sep 30, 2024
$1.41B
Oct 21, 2025
Q2
2025
Jun 30, 2024
$2.77B
Jul 17, 2025
Q1
2025
Mar 31, 2024
$3.02B
Apr 22, 2025
Q3
2024
Sep 30, 2023
$1.76B
Oct 17, 2024
Q2
2024
Jun 30, 2023
$2.63B
Jul 17, 2024
Q1
2024
Mar 31, 2023
$2.83B
Apr 18, 2024
Q3
2023
Dec 31, 2022
$8.28B
Oct 18, 2023
Q3
2023
Sep 30, 2022
$2.25B
Oct 18, 2023
Q2
2023
Jun 30, 2022
$2.35B
Sep 29, 2023
Q1
2023
Mar 31, 2022
$2.43B
Apr 19, 2023
Q3
2023
Dec 31, 2021
$7.56B
Oct 18, 2023
Q3
2022
Sep 30, 2021
$2.06B
Oct 19, 2022
Q2
2022
Jun 30, 2021
$2.08B
Jul 20, 2022
Q1
2022
Mar 31, 2021
$2.16B
Apr 20, 2022
Q3
2023
Dec 31, 2020
$6.36B
Oct 18, 2023
Q3
2021
Sep 30, 2020
$201.00M
Oct 20, 2021
Q2
2021
Jun 30, 2020
$3.36B
Jul 21, 2021